reference/11234830

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11234830

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1310
issn	0149-2918
issueIdentifier	8
pageRange	1295-1310
publicationName	Clinical Therapeutics
startingPage	1295
bibliographicCitation	De Cock E, Hutton J, Canney P, Body JJ, Barrett-Lee P, Neary MP, Lewis G. Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom. Clin Ther. 2005 Aug;27(8):1295–310. doi: 10.1016/j.clinthera.2005.08.006. PMID: 16199254.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4afe50cdd830f1b2a817c0df20cb0966 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_327466298041fcd2dcdf59db1ca89cdf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5aa9c17cfe7ec683a905601123ffff9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6246-7357 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75cee8dce895a73e5471b5102f338577 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe7128d228565361a997af4ca556c138 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a8a4fc4e6b109e413676b0259f859b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02bae992f333ce17514d91d7634a5304
date	200508
identifier	https://pubmed.ncbi.nlm.nih.gov/16199254 https://doi.org/10.1016/j.clinthera.2005.08.006
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2822 https://portal.issn.org/resource/ISSN/0149-2918
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom
discusses	http://id.nlm.nih.gov/mesh/M0071565 http://id.nlm.nih.gov/mesh/M0011048 http://id.nlm.nih.gov/mesh/M0472480 http://id.nlm.nih.gov/mesh/M0197524 http://id.nlm.nih.gov/mesh/M0006519 http://id.nlm.nih.gov/mesh/M0234600 http://id.nlm.nih.gov/mesh/M0010538
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001859Q000401 http://id.nlm.nih.gov/mesh/D001859Q000188 http://id.nlm.nih.gov/mesh/D004164Q000627 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D007093Q000627 http://id.nlm.nih.gov/mesh/D003362 http://id.nlm.nih.gov/mesh/D001859Q000556 http://id.nlm.nih.gov/mesh/D050071Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007093Q000008 http://id.nlm.nih.gov/mesh/D019057 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D050071Q000008 http://id.nlm.nih.gov/mesh/D050071Q000191 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D007093Q000191 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000077557 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D004164Q000191 http://id.nlm.nih.gov/mesh/D000077268 http://id.nlm.nih.gov/mesh/D006113 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004164Q000008 http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D006728Q000627 http://id.nlm.nih.gov/mesh/D000077211
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2088 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4674 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60852 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128627634 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129624957 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658

Total number of triples: 71.